CROWN HOLDINGS SCHEDULES THIRD QUARTER 2024 EARNINGS CONFERENCE CALL
CROWN HOLDINGS SCHEDULES THIRD QUARTER 2024 EARNINGS CONFERENCE CALL
PR Newswire
TAMPA, Fla., Sept. 20, 2024
TAMPA, Fla., Sept. 20, 2024 /PRNewswire/ -- Crown Holdings, Inc. (NYSE:CCK) will release its earnings for the third quarter ended September 30, 2024 after the close of trading on the New York Stock Exchange on Thursday, October 17, 2024. The Company will hold a conference call to discuss these results at 9:00 a.m. (EDT) on Friday, October 18, 2024.
The dial-in numbers for the conference call are (630) 395-0194 or toll-free (888) 324-8108 and the access password is "packaging". A replay of the conference call will be available for a one-week period ending at midnight on October 25, 2024. The telephone numbers for the replay are (203) 369-3268 or toll free (800) 391-9851. A live webcast of the call will be made available to the public on the internet at the Company's website, www.crowncork.com.
Crown Holdings, Inc., through its subsidiaries, is a worldwide leader in the design, manufacture and sale of packaging products for consumer goods and industrial products. World headquarters are located in Tampa, Florida.
For more information, contact Corporate Communications at (215) 602-2653.
View original content:https://www.prnewswire.com/news-releases/crown-holdings-schedules-third-quarter-2024-earnings-conference-call-302254198.html
SOURCE Crown Holdings, Inc.
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks